Claudine Serradeil-Le Gal
Exploratory Research Department
Sanofi-Synthelabo Recherche
Toulouse
and INSERM U-469
France
Name/email consistency: high
- SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor. Serradeil-Le Gal, C., Valette, G., Foulon, L., Germain, G., Advenier, C., Naline, E., Bardou, M., Martinolle, J.P., Pouzet, B., Raufaste, D., Garcia, C., Double-Cazanave, E., Pauly, M., Pascal, M., Barbier, A., Scatton, B., Maffrand, J.P., Le Fur, G. J. Pharmacol. Exp. Ther. (2004)
- Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. Serradeil-Le Gal, C., Wagnon, J., Simiand, J., Griebel, G., Lacour, C., Guillon, G., Barberis, C., Brossard, G., Soubrié, P., Nisato, D., Pascal, M., Pruss, R., Scatton, B., Maffrand, J.P., Le Fur, G. J. Pharmacol. Exp. Ther. (2002)
- Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Serradeil-Le Gal, C., Wagnon, J., Valette, G., Garcia, G., Pascal, M., Maffrand, J.P., Le Fur, G. Prog. Brain Res. (2002)
- An overview of SR121463, a selective non-peptide vasopressin V(2) receptor antagonist. Serradeil-Le Gal, C. Cardiovasc. Drug. Rev (2001)
- Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463. Serradeil-Le Gal, C., Raufaste, D., Double-Cazanave, E., Guillon, G., Garcia, C., Pascal, M., Maffrand, J.P. Kidney Int. (2000)